Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Should metformin remain the first-line therapy for treatment of type 2 diabetes?
Chelsea Baker, Cimmaron Retzik-Stahr, Vatsala Singh, et al.
Therapeutic Advances in Endocrinology and Metabolism (2021) Vol. 12
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Phagocytosis, Degranulation and Extracellular Traps Release by Neutrophils—The Current Knowledge, Pharmacological Modulation and Future Prospects
Barbara Gierlikowska, Albert Stachura, Wojciech Gierlikowski, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 82
Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
Francesco Agostini, Anna Masato, Luigi Bubacco, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 398-398
Open Access | Times Cited: 63
Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023
Harold Bays, Shagun Bindlish, Tiffany Lowe Clayton
Obesity Pillars (2023) Vol. 5, pp. 100056-100056
Open Access | Times Cited: 32
Advances in the management of type 2 diabetes in adults
Rodolfo J. Galindo, Jennifer M. Trujillo, Cecilia C. Low Wang, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000372-e000372
Open Access | Times Cited: 30
Glucose-Responsive Microparticle-Loaded Dissolving Microneedles for Selective Delivery of Metformin: A Proof-of-Concept Study
Nur Syafika, Sumayya Binti Abdul Azis, Cindy Kristina Enggi, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 2, pp. 1269-1284
Closed Access | Times Cited: 29
A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes
Zoheir A. Damanhouri, Huda M. Alkreathy, Fawaz Abdullah Alharbi, et al.
International Journal of Medical Sciences (2023) Vol. 20, Iss. 1, pp. 142-150
Open Access | Times Cited: 27
View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences
Guglielmina Froldi
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 478-478
Open Access | Times Cited: 15
Epithelial-Mesenchymal Transition: A Fundamental Cellular and Microenvironmental Process in Benign and Malignant Prostate Pathologies
Aviv Philip Goncharov, Nino Vashakidze, Gvantsa Kharaishvili
Biomedicines (2024) Vol. 12, Iss. 2, pp. 418-418
Open Access | Times Cited: 11
A Comprehensive Review of Metabolic Syndrome and Its Role in Cardiovascular Disease and Type 2 Diabetes Mellitus: Mechanisms, Risk Factors, and Management
Rushikesh H Dhondge, Sachin Agrawal, Rajvardhan Patil, et al.
Cureus (2024)
Open Access | Times Cited: 9
Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes
Yoscelina Estrella Martínez-López, Daniel Neri-Rosario, Diego Esquivel-Hernández, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Pharmacotherapeutic Considerations on Telomere Biology: The Positive Effect of Pharmacologically Active Substances on Telomere Length
Miruna-Maria Apetroaei, Persefoni Fragkiadaki, Bruno Ștefan Velescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7694-7694
Open Access | Times Cited: 7
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Diabetic Retinopathy at a Tertiary Care Center
Julia H. Joo, Neha Sharma, Jacqueline K. Shaia, et al.
Ophthalmology Science (2024) Vol. 4, Iss. 6, pp. 100547-100547
Open Access | Times Cited: 6
A Microstirring Oral Pill for Improving the Glucose-Lowering Effect of Metformin
Rodolfo Mundaca‐Uribe, Maya Holay, Amal Abbas, et al.
ACS Nano (2023) Vol. 17, Iss. 10, pp. 9272-9279
Closed Access | Times Cited: 13
Post-Translational Modifications and Diabetes
Chiranjeev Sharma, Abu Hamza, Emily Boyle, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 310-310
Open Access | Times Cited: 5
Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus
Sahar Mohamed El-Haggar, Yasser Mostafa Hafez, Amira Mohamed El Sharkawy, et al.
Medicina Clínica (2024) Vol. 163, Iss. 2, pp. 53-61
Closed Access | Times Cited: 5
Cardiovascular complications of diabetes
Avisha Shah, Ameesh Isath, Wilbert S. Aronow
Expert Review of Endocrinology & Metabolism (2022) Vol. 17, Iss. 5, pp. 383-388
Closed Access | Times Cited: 19
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Christoph Hieber, Stephan Grabbe, Matthias Bros
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1085-1085
Open Access | Times Cited: 12
Multiple nanotechnological approaches using natural compounds for diabetes management
Ozana Andreea Stoleru, Ana Flavia Burlec, Cornelia Mircea, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 1, pp. 267-287
Closed Access | Times Cited: 4
Chlorpropamide-cyclodextrin inclusion complexes, theoretical basis of stability
Sara E. Pérez-Figueroa, Emir A. Galván-García, Didier Nivón-Ramírez, et al.
Journal of Molecular Liquids (2024) Vol. 396, pp. 123995-123995
Closed Access | Times Cited: 4
Type 2 Diabetes and Cognitive Decline: A Neurovascular Perspective
Arbind Kumar Choudhary
Chronicle of Diabetes Research and Practice (2025) Vol. 4, Iss. 1, pp. 31-41
Closed Access
Metformin as a disease-modifying therapy in osteoarthritis: bridging metabolism and joint health
Iryna Halabitska, Pavlo Petakh, Oleksandr Kamyshnyi
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Sodium‐glucose cotransporter‐2 inhibitors and subtype‐specific dementia risk: A multinational and multiethnic cohort study
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Impact of Metformin Therapy on Vitamin B12 Levels in Patients With Type 2 Diabetes Mellitus
Sahar H. Mahmoud, Fatma R. Elfargani, Nagwa Mohamed, et al.
Endocrinology Diabetes & Metabolism (2025) Vol. 8, Iss. 3
Open Access
Prevalence of medication adherence and glycemic control among patients with type 2 diabetes and influencing factors: A cross-sectional study
Budi Suprapti, Zamrotul Izzah, Ade Giriayu Anjani, et al.
Global Epidemiology (2023) Vol. 5, pp. 100113-100113
Open Access | Times Cited: 10
mTORC1 and SGLT2 Inhibitors—A Therapeutic Perspective for Diabetic Cardiomyopathy
Sumit Saha, Xianjun Fang, Christopher D. Green, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15078-15078
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top